DAB PHARMA INNOVATIONS LIMITED

Company Registration Number:
12539073 (England and Wales)

Unaudited micro entity accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

DAB PHARMA INNOVATIONS LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

DAB PHARMA INNOVATIONS LIMITED

Company Information

for the Period Ended 31 March 2025




Registered office: 23
Barwick Avenue
Bury St. Edmunds
England
IP32 6TW
Company Registration Number: 12539073 (England and Wales)

DAB PHARMA INNOVATIONS LIMITED

Balance sheet

As at 31 March 2025


2025
£

2024
£
Called up share capital not paid: 0 0
Fixed Assets: 16,263 32,636
Current assets: 54,421 78,639
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 0 ) ( 0 )
Net current assets (liabilities): 54,421 78,639
Total assets less current liabilities: 70,684 111,275
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 70,684 111,275
Capital and reserves: 70,684 111,275

DAB PHARMA INNOVATIONS LIMITED

Balance sheet continued

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 31 December 2025
And Signed On Behalf Of The Board By:

Name: Gordon McMurray
Status: Director

The notes form part of these financial statements

DAB PHARMA INNOVATIONS LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Employee Information

    Average number of employees: 0

DAB PHARMA INNOVATIONS LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Off balance sheet disclosure

    No